News that makes you smarter and richer... For free.

Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.4900

-0.0400

(-2.61%)

At close: 04:00PM EDT

1.3800

-0.11

(-7.38%)

After hours:

07:59PM EDT

Loading interactive chart…

Simply Wall St.
How Many Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Shares Do Institutions Own?
Every investor in Infinity Pharmaceuticals, Inc. ( NASDAQ:INFI ) should be aware of the most powerful shareholder...
Zacks
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
Infinity (INFI) delivered earnings and revenue surprises of 7.14% and 1.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
CAMBRIDGE, Mass., August 09, 2022--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) ("Infinity" or the "Company"), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced its second quarter 2022 financial results, unveiled new positive data from the Phase 2 MARIO-275 clinical trial, and provided a business update.